• Researchers have developed a new drug called αPD-L1 × αCD3 BIPE that helps the immune system better target and kill non-small cell lung cancer cells by connecting cancer-fighting...
Researchers have developed a new type of engineered immune cell, called “fifth-generation CAR T cells,” to fight cholangiocarcinoma, a severe bile duct cancer that is often hard to treat....
• Researchers have developed a new drug called αPD-L1 × αCD3 BIPE that helps the immune system better target and kill non-small cell lung cancer cells by connecting cancer-fighting...
Researchers have developed a new method to treat multiple myeloma, a type of blood cancer. They engineered a type of immune cell called T cells to produce and release...
Researchers are exploring a new treatment strategy for multiple myeloma, a type of blood cancer that often becomes resistant to therapy. They found that a low dose of the...
Scientists have created a new type of drug, called KTX207, that works by specifically instructing cells to destroy certain proteins, rather than just blocking them. This new drug targets...
Researchers have developed a new approach to T cell therapy that is more effective and less toxic than current treatments. This new approach uses bispecific T cell engagers (BITEs)...
Researchers have developed a new approach to T cell therapy that is more effective in killing breast cancer cells. This new approach uses bispecific T cell engagers (BITEs) to...
Researchers from Siriraj Hospital, Mahidol University in Thailand have successfully used a closed, semi-automated production platform to produce anti-CD19 CAR-T cells for the treatment of relapsed/refractory B-cell malignancies. This...
Researchers have discovered that cordycepin and an extract from the Cordyceps militaris mushroom can make cancer cells more vulnerable to destruction by the immune system. The researchers found that...